Ballardini, Maria Pia
 Distribuzione geografica
Continente #
AS - Asia 211
NA - Nord America 192
EU - Europa 104
SA - Sud America 32
AF - Africa 4
OC - Oceania 1
Totale 544
Nazione #
US - Stati Uniti d'America 180
SG - Singapore 99
IT - Italia 50
VN - Vietnam 37
CN - Cina 35
BR - Brasile 25
HK - Hong Kong 13
DE - Germania 10
CA - Canada 8
FR - Francia 8
GB - Regno Unito 8
TR - Turchia 7
RU - Federazione Russa 6
UA - Ucraina 6
FI - Finlandia 5
IN - India 5
JP - Giappone 5
AR - Argentina 4
MX - Messico 4
ZA - Sudafrica 4
CH - Svizzera 3
IQ - Iraq 3
PL - Polonia 3
UZ - Uzbekistan 3
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
CO - Colombia 1
EC - Ecuador 1
ID - Indonesia 1
KG - Kirghizistan 1
LT - Lituania 1
NL - Olanda 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
Totale 544
Città #
Singapore 67
Ashburn 48
Beijing 17
San Jose 15
Santa Clara 15
Hong Kong 13
Ho Chi Minh City 12
Woodbridge 10
Council Bluffs 9
Assago 8
Fidenza 8
Hanoi 8
Los Angeles 8
Chandler 6
Jacksonville 6
Rome 6
Ferrara 5
Munich 5
New York 5
Parma 5
Tokyo 5
Dallas 4
Lauterbourg 4
Rio de Janeiro 4
Bern 3
Bologna 3
Hefei 3
Helsinki 3
London 3
Orem 3
Tashkent 3
Warsaw 3
Wilmington 3
Ankara 2
Brasília 2
Chicago 2
Da Nang 2
Haiphong 2
Hải Dương 2
Izmir 2
Manchester 2
Mexico City 2
Milan 2
Montreal 2
Phú Thọ 2
San Genesio Ed Uniti 2
Shanghai 2
São Paulo 2
Toronto 2
Traversetolo 2
Amsterdam 1
Annapolis 1
Azcapotzalco 1
Baghdad 1
Bari 1
Benevento 1
Bishkek 1
Biên Hòa 1
Boardman 1
Brussels 1
Bucharest 1
Bến Tre 1
Calgary 1
Cambé 1
Campinas 1
Can Tho 1
Capitão Poço 1
Center Line 1
Córdoba 1
Delhi 1
Denver 1
Dhaka 1
Erbil 1
Fairfield 1
Falkenstein 1
Franca 1
General Rodríguez 1
Goiás 1
Hengshui 1
Hollister 1
Indore 1
Istanbul 1
Jackson 1
Jiaxing 1
Jinan 1
Johannesburg 1
Kunming 1
KwaDukuza 1
Lagoa da Canoa 1
Lagoa da Prata 1
Las Vegas 1
Leawood 1
Lima 1
Lomas de Zamora 1
Maceió 1
Medellín 1
Minneapolis 1
Mérida 1
Nanjing 1
Newton Abbot 1
Totale 404
Nome #
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency 163
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era 144
How to increase the use of screening instruments in oncology settings in Italy 138
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study 109
Totale 554
Categoria #
all - tutte 2.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 2 0
2021/20227 0 1 0 0 0 0 0 0 1 3 1 1
2022/202311 1 0 0 1 2 4 1 0 1 1 0 0
2023/202414 0 1 0 0 6 0 1 2 0 2 0 2
2024/2025133 3 1 6 9 17 12 8 6 22 16 15 18
2025/2026342 48 24 26 40 53 23 46 24 24 34 0 0
Totale 554